Vertex Pharmaceuticals Inc (VRTX) stock
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3028% above fair value
$547.03−0.86 (-0.16%)
Close on Nov 11, 2026Market cap $138.65BP/E 31.8Yield –
Vertex Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Vertex Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was 38.0%. For fiscal 2025 it was 34.8%, against -2.1% the year before. The highest annual figure on record is 48.2% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 34.8% | +36.9 |
| FY2024 | Dec 31, 2024 | -2.1% | −40.9 |
| FY2023 | Dec 31, 2023 | 38.8% | −9.4 |
| FY2022 | Dec 31, 2022 | 48.2% | +11.5 |
| FY2021 | Dec 31, 2021 | 36.7% | −9.3 |
| FY2020 | Dec 31, 2020 | 46.0% | +17.3 |
| FY2019 | Dec 31, 2019 | 28.8% | +7.9 |
| FY2018 | Dec 31, 2018 | 20.8% | +15.9 |
| FY2017 | Dec 31, 2017 | 5.0% | +4.4 |
| FY2016 | Dec 31, 2016 | 0.6% | +45.8 |
| FY2015 | Dec 31, 2015 | -45.2% | +74.1 |
| FY2014 | Dec 31, 2014 | -119.3% | −69.0 |
| FY2013 | Dec 31, 2013 | -50.3% | −53.4 |
| FY2012 | Dec 31, 2012 | 3.1% | −5.0 |
| FY2011 | Dec 31, 2011 | 8.1% | +493.6 |
| FY2010 | Dec 31, 2010 | -485.5% | +117.1 |
| FY2009 | Dec 31, 2009 | -602.6% | −339.0 |
| FY2008 | Dec 31, 2008 | -263.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 37.4% | −1.4 |
| Q1 FY2026 | Mar 31, 2026 | 38.1% | +15.4 |
| Q4 FY2025 | Dec 31, 2025 | 37.8% | +2.6 |
| Q3 FY2025 | Sep 30, 2025 | 38.6% | −1.7 |
| Q2 FY2025 | Jun 30, 2025 | 38.8% | +171.7 |
| Q1 FY2025 | Mar 31, 2025 | 22.7% | −19.6 |
| Q4 FY2024 | Dec 31, 2024 | 35.2% | −4.0 |
| Q3 FY2024 | Sep 30, 2024 | 40.3% | −1.5 |
| Q2 FY2024 | Jun 30, 2024 | -132.9% | −174.0 |
| Q1 FY2024 | Mar 31, 2024 | 42.4% | +9.5 |
| Q4 FY2023 | Dec 31, 2023 | 39.3% | −5.6 |
| Q3 FY2023 | Sep 30, 2023 | 41.8% | −6.5 |
| Q2 FY2023 | Jun 30, 2023 | 41.2% | −9.2 |
| Q1 FY2023 | Mar 31, 2023 | 32.8% | −16.8 |
| Q4 FY2022 | Dec 31, 2022 | 44.9% | +2.5 |
| Q3 FY2022 | Sep 30, 2022 | 48.3% | −4.9 |
| Q2 FY2022 | Jun 30, 2022 | 50.4% | +52.5 |
| Q1 FY2022 | Mar 31, 2022 | 49.6% | −1.9 |
| Q4 FY2021 | Dec 31, 2021 | 42.3% | −3.5 |
| Q3 FY2021 | Sep 30, 2021 | 53.1% | +9.4 |
| Q2 FY2021 | Jun 30, 2021 | -2.1% | −49.2 |
| Q1 FY2021 | Mar 31, 2021 | 51.5% | +4.0 |
| Q4 FY2020 | Dec 31, 2020 | 45.8% | +6.8 |
| Q3 FY2020 | Sep 30, 2020 | 43.7% | +33.2 |
| Q2 FY2020 | Jun 30, 2020 | 47.1% | +18.4 |
| Q1 FY2020 | Mar 31, 2020 | 47.5% | +15.3 |
| Q4 FY2019 | Dec 31, 2019 | 39.0% | +24.3 |
| Q3 FY2019 | Sep 30, 2019 | 10.5% | −15.8 |
| Q2 FY2019 | Jun 30, 2019 | 28.7% | +5.7 |
| Q1 FY2019 | Mar 31, 2019 | 32.2% | +12.1 |
| Q4 FY2018 | Dec 31, 2018 | 14.7% | −4.6 |
| Q3 FY2018 | Sep 30, 2018 | 26.2% | +82.6 |
| Q2 FY2018 | Jun 30, 2018 | 23.0% | +13.3 |
| Q1 FY2018 | Mar 31, 2018 | 20.1% | −17.8 |
| Q4 FY2017 | Dec 31, 2017 | 19.3% | +10.7 |
| Q3 FY2017 | Sep 30, 2017 | -56.4% | −51.9 |
| Q2 FY2017 | Jun 30, 2017 | 9.7% | – |
| Q1 FY2017 | Mar 31, 2017 | 37.9% | – |
| Q4 FY2016 | Dec 31, 2016 | 8.6% | – |
| Q3 FY2016 | Sep 30, 2016 | -4.5% | – |
See a number that looks wrong?